In focus · trending topic

Complement Factor D

26 stories · following the connections

Achillion Reports Third Quarter 2016 Financial Results And Provides Update On Clinical Programs

By Nasdaq OMXNov 3, 2016, 1:00 PM UTC

Achillion Presents Novel Research on Factor D Inhibition at the XXVIth International Complement Workshop

By Nasdaq OMXSep 6, 2016, 10:05 AM UTC

Achillion to Present at Two Upcoming Investor Conferences

By Nasdaq OMXSep 1, 2016, 10:05 AM UTC

Achillion to Present at the 2016 Wedbush PacGrow Healthcare Conference

By Nasdaq OMXAug 9, 2016, 10:05 AM UTC

Achillion to Present at Two Upcoming Investor Conferences

By Nasdaq OMXMar 3, 2016, 11:05 AM UTC

Achillion Reports 2015 Fourth Quarter and Year-End Financial Results

By Nasdaq OMXFeb 25, 2016, 11:05 AM UTC

Achillion Initiates Phase 1 Study of ACH-4471, First Orally-Administered Small Molecule Complement Factor D Inhibitor

By Nasdaq OMXFeb 11, 2016, 11:05 AM UTC

Achillion to Present at the Leerink Partners 5th Annual Global Healthcare Conference

By Nasdaq OMXFeb 8, 2016, 9:05 PM UTC